353 related articles for article (PubMed ID: 16518373)
1. Evolving knowledge and therapy of inflammatory bowel disease.
Korzenik JR; Podolsky DK
Nat Rev Drug Discov; 2006 Mar; 5(3):197-209. PubMed ID: 16518373
[TBL] [Abstract][Full Text] [Related]
2. Novel strategies to attenuate immune activation in Crohn's disease.
Bamias G; Cominelli F
Curr Opin Pharmacol; 2006 Aug; 6(4):401-7. PubMed ID: 16753341
[TBL] [Abstract][Full Text] [Related]
3. Gut microflora: a new target for therapeutic approaches in inflammatory bowel disease.
Mitsuyama K; Sata M
Expert Opin Ther Targets; 2008 Mar; 12(3):301-12. PubMed ID: 18269340
[TBL] [Abstract][Full Text] [Related]
4. [Role of intestinal flora in inflammatory bowel disease and probiotics place in their management].
Belkahla N; Maamouri N; Ouerghi H; Ben Ammar A
Tunis Med; 2005 Mar; 83(3):132-6. PubMed ID: 15929439
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms and efficacy of immunobiologic therapies for inflammatory bowel diseases.
Ghosh N; Chaki R; Mandal V; Lin GD; Mandal SC
Int Rev Immunol; 2010; 29(1):4-37. PubMed ID: 20100080
[TBL] [Abstract][Full Text] [Related]
6. Evidence for the use of probiotics and prebiotics in inflammatory bowel disease: a review of clinical trials.
Hedin C; Whelan K; Lindsay JO
Proc Nutr Soc; 2007 Aug; 66(3):307-15. PubMed ID: 17637082
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic approaches in inflammatory bowel disease based on the immunopathogenesis.
Siegmund B; Zeitz M
Rocz Akad Med Bialymst; 2004; 49():22-30. PubMed ID: 15631310
[TBL] [Abstract][Full Text] [Related]
8. Granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, and other immunomodulatory therapies for the treatment of infectious diseases in solid organ transplant recipients.
Page AV; Liles WC
Curr Opin Organ Transplant; 2008 Dec; 13(6):575-80. PubMed ID: 19060545
[TBL] [Abstract][Full Text] [Related]
9. Clinical usefulness of probiotics in inflammatory bowel diseases.
Mach T
J Physiol Pharmacol; 2006 Nov; 57 Suppl 9():23-33. PubMed ID: 17242485
[TBL] [Abstract][Full Text] [Related]
10. Understanding why probiotic therapies can be effective in treating IBD.
Fedorak RN
J Clin Gastroenterol; 2008 Sep; 42 Suppl 3 Pt 1():S111-5. PubMed ID: 18806699
[TBL] [Abstract][Full Text] [Related]
11. The pathophysiologic rationale for biological therapies in inflammatory bowel disease.
Gordon JN; Di Sabatino A; Macdonald TT
Curr Opin Gastroenterol; 2005 Jul; 21(4):431-7. PubMed ID: 15930983
[TBL] [Abstract][Full Text] [Related]
12. Translational research in inflammatory bowel disease.
Abreu MT; Sparrow MP
Mt Sinai J Med; 2006 Dec; 73(8):1067-73. PubMed ID: 17285196
[TBL] [Abstract][Full Text] [Related]
13. Recent advances in biological therapy for inflammatory bowel disease.
Kurtovic J; Segal I
Trop Gastroenterol; 2004; 25(1):9-14. PubMed ID: 15303463
[TBL] [Abstract][Full Text] [Related]
14. [Probiotics for inflammatory bowel disease].
Iizuka H; Takaishi H; Hibi T
Nihon Rinsho; 2005 May; 63(5):776-80. PubMed ID: 15881169
[TBL] [Abstract][Full Text] [Related]
15. Prebiotics, synbiotics and inflammatory bowel disease.
Steed H; Macfarlane GT; Macfarlane S
Mol Nutr Food Res; 2008 Aug; 52(8):898-905. PubMed ID: 18383235
[TBL] [Abstract][Full Text] [Related]
16. Immunological disorders in inflammatory bowel disease and immunotherapeutic implications.
Amati L; Caradonna L; Jirillo E; Caccavo D
Ital J Gastroenterol Hepatol; 1999 May; 31(4):313-25. PubMed ID: 10425578
[TBL] [Abstract][Full Text] [Related]
17. After interleukin-12p40, are interleukin-23 and interleukin-17 the next therapeutic targets for inflammatory bowel disease?
Zhang Z; Hinrichs DJ; Lu H; Chen H; Zhong W; Kolls JK
Int Immunopharmacol; 2007 Apr; 7(4):409-16. PubMed ID: 17321463
[TBL] [Abstract][Full Text] [Related]
18. Biologic therapy for inflammatory bowel disease.
Ardizzone S; Bianchi Porro G
Drugs; 2005; 65(16):2253-86. PubMed ID: 16266194
[TBL] [Abstract][Full Text] [Related]
19. Inflammatory bowel disease: current insights into pathogenesis and new therapeutic options; probiotics, prebiotics and synbiotics.
Geier MS; Butler RN; Howarth GS
Int J Food Microbiol; 2007 Apr; 115(1):1-11. PubMed ID: 17137666
[TBL] [Abstract][Full Text] [Related]
20. Inflammatory bowel disease: potential therapeutic strategies.
Nielsen OH; Vainer B; Bregenholt S; Claësson MH; Bishop PD; Kirman I
Cytokines Cell Mol Ther; 1997 Dec; 3(4):267-81. PubMed ID: 9740355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
